Clinical data monitoring during COVID-19 pandemic: an experience from a regulatory trial in India
DOI:
https://doi.org/10.18203/2349-3259.ijct20211465Keywords:
Clinical data monitoring, Source data verification, COVID–19, Pandemic, Remote or central monitoringAbstract
The essence of any clinical or healthcare related discovery is its methodologically sound clinical research and clinical data monitoring. This eventually helps the clinicians to understand the best possible clinical management pathways or patient management at all the levels of healthcare system. The pandemic has had an impact on clinical trial data monitoring as well. New or mixed approaches to routine monitoring have been introduced to ensure the quality of the overall research in these challenging times and are being tested for efficacy, cost-effectiveness while keeping ethical considerations as the main priority. This write up intends to highlight a few steps taken to ensure data integrity and participants’ safety and rights.
References
Nielsen E, Hyder D, Deng C. A Data-Driven Approach to Risk-Based Source Data Verification. Ther Innov Regul Sci. 2014;48(2):173-80.
Getz KA. Low-hanging fruit in the fight against inefficiency. Appl Clin Trials. 2011;20(3):30-2.
Van der Velde ET, Atsma DE, Foeken H, Witteman TA, Hoekstra WH. Remote monitoring of patients with implanted devices: data exchange and integration. Eur J Prev Cardiol. 2013;20(2):8-12.
Stafford PB, Garrett A. Using Real-time Data to Drive Better Decisions, Faster. Drug Info J. 2011;45(4):495-502.
Patel MK. Remote Site Monitoring: The Future of Clinical Research. Curr Trends Biomedical Eng Biosci. 2017;9(5).
Mealer M, Kittelson J, Thompson BT. Remote source document verification in two national clinical trials networks: a pilot study. PLoS One. 2013;8(12):e81890.
Cowie MR, Blomster JI, Curtis LH. Electronic health records to facilitate clinical research. Clin Res Cardiol. 2017;106:1-9.
Baigent C, Harrell FE, Buyse M, Emberson JR, Altman DG. Ensuring trial validity by data quality assurance and diversification of monitoring methods. Clin Trials. 2008;5(1):49-55.
Marchenko O, Fedorov V, Lee JJ, Nolan C, Pinheiro J. Adaptive Clinical Trials: Overview of Early-Phase Designs and Challenges. Ther Innov Regul Sci. 2014;48(1):20-30.
